Wordt geladen...
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition
Heart failure affects approximately 5.7 million people in the United States alone. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, and aldosterone antagonists have improved mortality in patients with heart failure and reduced ejection fraction, but mortality r...
Bewaard in:
| Gepubliceerd in: | Circulation |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4800749/ https://ncbi.nlm.nih.gov/pubmed/26976916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.115.018622 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|